Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Hypericin diagnostic - Sanochemia

Next Previous
X
Search
Drug Profile

Hypericin diagnostic - Sanochemia

Alternative Names: Polyvinylpyrrolidone-hypericin; Povidone-hypericin; PVP-hypericin; SPH-3542; Vidon

Latest Information Update: 27 Feb 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Planta Natural Products
  • Developer Austrian Academy of Sciences; Sanochemia Pharmazeutika
  • Class Anthraquinones; Anti-inflammatories; Antidepressants; Antineoplastics; Antipsoriatics; Antivirals; Cytostatics; Perylenes; Polycyclic compounds; Radiation-sensitising agents; Skin disorder therapies; Small molecules
  • Mechanism of Action Photosensitisers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Bladder cancer

Most Recent Events

  • 24 Feb 2023 Discontinued - Preclinical for Bladder cancer in Austria (Intravesicular) (Sanochemia Diagnostics pipeline, February 2023)
  • 28 Jan 2020 No recent reports of development identified for preclinical development in Bladder-cancer in Austria (Intravesicular, Injection)
  • 31 Jan 2018 PVP-hypericin is still in preclinical development for Bladder cancer in Austria (Sanochemia Pharmazeutika pipeline, January 2018)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top